| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Diabetes Endocrinol 2018; 6: 464–75
|
|
|
2018
|
6 |
8 |
p. e16
|
artikel
|
| 2 |
Correction to Lancet Diabetes Endocrinol 2018; 6:627–36
|
|
|
2018
|
6 |
8 |
p. e16
|
artikel
|
| 3 |
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
|
Zhu, Dalong
|
|
2018
|
6 |
8 |
p. 627-636
|
artikel
|
| 4 |
Dulaglutide and renal protection in type 2 diabetes
|
Cherney, David Z I
|
|
2018
|
6 |
8 |
p. 588-590
|
artikel
|
| 5 |
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
|
Tuttle, Katherine R
|
|
2018
|
6 |
8 |
p. 605-617
|
artikel
|
| 6 |
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
|
Bowman, Pamela
|
|
2018
|
6 |
8 |
p. 637-646
|
artikel
|
| 7 |
Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk
|
Retnakaran, Ravi
|
|
2018
|
6 |
8 |
p. 599
|
artikel
|
| 8 |
Investigation of primary aldosteronism in patients with resistant hypertension
|
Choy, Kay Weng
|
|
2018
|
6 |
8 |
p. 599-600
|
artikel
|
| 9 |
Investigation of primary aldosteronism in patients with resistant hypertension – Authors' reply
|
Williams, Bryan
|
|
2018
|
6 |
8 |
p. 600-601
|
artikel
|
| 10 |
New hope for glucokinase activators in type 2 diabetes?
|
Scheen, André J
|
|
2018
|
6 |
8 |
p. 591-593
|
artikel
|
| 11 |
Opening the door to treating ageing as a disease
|
The Lancet Diabetes & Endocrinology,
|
|
2018
|
6 |
8 |
p. 587
|
artikel
|
| 12 |
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
|
Schlumberger, Martin
|
|
2018
|
6 |
8 |
p. 618-626
|
artikel
|
| 13 |
Precision medicine in KCNJ11 permanent neonatal diabetes
|
Greeley, Siri Atma W
|
|
2018
|
6 |
8 |
p. 594-595
|
artikel
|
| 14 |
Preferred strategy for postsurgical thyroid ablation in low-risk thyroid cancer
|
Pacini, Furio
|
|
2018
|
6 |
8 |
p. 590-591
|
artikel
|
| 15 |
Research digest: heart failure in diabetes comes into focus
|
Sattar, Naveed
|
|
2018
|
6 |
8 |
p. 603
|
artikel
|
| 16 |
Risk–benefit profile of intensive blood pressure treatment
|
Neves, João Sérgio
|
|
2018
|
6 |
8 |
p. 601-602
|
artikel
|
| 17 |
Risk–benefit profile of intensive blood pressure treatment – Authors' reply
|
Beddhu, Srinivasan
|
|
2018
|
6 |
8 |
p. 602
|
artikel
|
| 18 |
Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials
|
Yeap, Bu B
|
|
2018
|
6 |
8 |
p. 659-672
|
artikel
|
| 19 |
The physiology of endocrine systems with ageing
|
van den Beld, Annewieke W
|
|
2018
|
6 |
8 |
p. 647-658
|
artikel
|
| 20 |
TV advertising and childhood obesity in the UK
|
Burki, Talha Khan
|
|
2018
|
6 |
8 |
p. 604
|
artikel
|
| 21 |
Using big data for non-communicable disease surveillance
|
Balicer, Ran D
|
|
2018
|
6 |
8 |
p. 595-598
|
artikel
|
Tijdschrift beschrijving